Watch the recording of the webinar from Wednesday, October 13thLearn More
Find answers to questions regarding the commission, medicinal cannabis, personal use, cannabis business, social equity, and more.LEARN MORE
Awards and denial decisions made on 14 cannabis cultivation and vertically integrated companies
TRENTON – The Cannabis Regulatory Commission has accepted the recommendation to approve 14 of the 2019 medicinal cannabis business applications that had been previously held up due to a court-ordered stay of the review process. Ten applications for cultivation permits and four applications for vertically integrated permits were approved and can begin preparations to serve New Jersey’s medicinal cannabis patients. Because of increasing patient need, five more cultivation permits were awarded than had been planned in 2019.
“The current alternative treatment centers have not kept pace with patient need,” said CRC Chairwoman Dianna Houenou. “We constantly hear from patients that prices are too high and that there are too few dispensaries with too few product options. The situation has not changed with the legalization of recreational cannabis. Our priority is to our patients and increasing the planned number of medicinal cannabis operators in the market will greatly benefit them.”
Twelve alternative treatment centers and satellite locations across New Jersey currently serve 118,882 medicinal cannabis patients.